Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
Image: MarketWatch
ad slot · in-content video 16:9
Coverage
Coverage
- Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.